Canalevia-CA1 (Crofelemer) Delayed-Release Tablets, 125mg

Product Description

Canalevia-CA1 is a FDA conditionally approved product to treat chemotherapy-induced diarrhea (CID) in dogs. Currently, treatment for this condition is not adequately addressed by other available medications. Canalevia-CA1 fills a gap in available treatment options, easing the burden of illness and providing a well-tolerated treatment for CID in dogs. Canalevia-CA1 has a novel mechanism of action that normalizes the fluid influx into the intestinal lumen that can improve the quality of life for the dog.  

Canalevia-CA1 treats CID by modulating the hypersecretion of Cl  in diarrhea and normalizes fluid influx into the intestinal lumen. Secretory diarrhea (intestinal fluid secretion) is driven by active transepithelial Cl  secretion, which creates the electrochemical force for paracellular Na+ secretion and the osmotic driving force for transcellular fluid secretion.

Recommended Dosage

Use as directed by your veterinarian. 

Storage Instructions

Store at 68 F to 77 F. 

All prescription items are Non-Refundable and Non-Returnable.